tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
Stock Analysis
Analyst Forecasts
Technical Analysis
New
Chart
Earnings
Dividends
Financials
News & Insights
Insider Trading
Hedge Funds
Similar Stocks
Risk Analysis
reports

Gain Therapeutics (GANX) Stock News & Sentiment

106 Followers
Gain Therapeutics price target raised to $5.75 from $4 at Chardan
The FlyGain Therapeutics price target raised to $5.75 from $4 at Chardan
1d ago
GANX
Gain sees dossier submission for Phase 1 clinical trial of GT-0228 by mid 2023
The FlyGain sees dossier submission for Phase 1 clinical trial of GT-0228 by mid 2023
5d ago
GANX
Gain Therapeutics sees completion of IND enabling studies of GT-02287 in 1H 2023
The FlyGain Therapeutics sees completion of IND enabling studies of GT-02287 in 1H 2023
5d ago
GANX
Gain Therapeutics reports FY22 EPS ($1.48), consensus ($1.51)
The FlyGain Therapeutics reports FY22 EPS ($1.48), consensus ($1.51)
5d ago
GANX
Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update
Press ReleasesGain Therapeutics Reports Full Year 2022 Financial Results and Business Update
5d ago
GANX
Gain Therapeutics announces grant award by Eurostars with Innosuisse
The FlyGain Therapeutics announces grant award by Eurostars with Innosuisse
7d ago
GANX
Gain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research Program
Press ReleasesGain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research Program
7d ago
GANX
More GANX News >

GANX News on the Web

Chardan Capital Sticks to Its Buy Rating for Gain Therapeutics (GANX)
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Iovance Biotherapeutics (IOVA), Gain Therapeutics (GANX)
TipRanks News
Bullish
Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update
Yahoo Finance
Neutral
Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders
Yahoo Finance
Neutral
Gain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research Program
Yahoo Finance
Neutral
Is Gain Therapeutics Inc (GANX) Stock About to Get Hot Friday?
Investors Observer
Neutral
Champions Oncology, Inc. (CSBR) Reports Q3 Loss, Tops Revenue Estimates
Zacks
Neutral
Is Gain Therapeutics Inc (GANX) Stock a Bad Value Monday?
Investors Observer
Neutral

News Score - Last 7 Days

Positive
GANX
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GANX’s Media Buzz Sentiment?
5 articles about GANX were published this week. In an average week, 2.5 articles are published.
    What is GANX’s weekly average amount of articles?
    In an average week, 2.5 articles about GANX are published.
      What is GANX’s News Sentiment?
      100% of articles about GANX were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        GBIOGeneration Bio
        REGNRegeneron
        CUECue Biopharma
        VORVor Biopharma
        0RGICOSMO Pharmaceuticals N.V.
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing